Table 2.
Correlation analysis between lncRNA and has-mir-330-5p or lncRNA and CDK4/6 in OV determined by starBase database.
lncRNA | miRNA | lncRNA and has-mir-330-5p R-value | lncRNA and has-mir-330-5p P-value | lncRNA and CDK4 R-value | lncRNA and CDK4 P-value | lncRNA and CDK6 R-value | lncRNA and CDK6 P-value |
---|---|---|---|---|---|---|---|
LRRC75A-AS1 | hsa-miR-330-5p | −0.272 | 0.000000087* | 0.206 | 0.0000525* | 0.13 | 0.0114* |
AC124312.3 | hsa-miR-330-5p | −0.155 | 0.00252* | 0.063 | 2.19E-01 | 0.243 | 1.70E-06 |
LINC00921 | hsa-miR-330-5p | −0.1 | 0.0519* | −0.209 | 0.0000425* | 0.094 | 6.64E-02 |
AC026471.1 | hsa-miR-330-5p | −0.124 | 0.0163* | 0.08 | 1.20E-01 | 0.069 | 1.79E-01 |
AC004943.2 | hsa-miR-330-5p | −0.108 | 0.0366* | 0.259 | 0.000000316* | 0.11 | 0.033* |
AC092127.1 | hsa-miR-330-5p | 0.05 | 3.34E-01 | −0.093 | 7.05E-02 | 0.142 | 5.54E-03 |
AC138028.6 | hsa-miR-330-5p | 0.126 | 1.43E-02 | −0.235 | 3.66E-06 | 0.127 | 1.33E-02 |
AC092384.3 | hsa-miR-330-5p | 0.049 | 3.41E-01 | −0.066 | 1.98E-01 | 0.03 | 5.66E-01 |
AC113189.2 | hsa-miR-330-5p | −0.018 | 7.27E-01 | 0.021 | 6.82E-01 | 0.135 | 8.45E-03 |
AC113189.4 | hsa-miR-330-5p | 0.043 | 4.11E-01 | 0.108 | 3.59E-02 | 0.149 | 3.73E-03 |
AC016876.2 | hsa-miR-330-5p | 0.097 | 6.01E-02 | −0.123 | 1.68E-02 | −0.121 | 1.85E-02 |
AC005304.2 | hsa-miR-330-5p | 0.009 | 8.55E-01 | −0.033 | 5.17E-01 | −0.022 | 6.71E-01 |
MEG3 | hsa-miR-330-5p | 0.031 | 5.47E-01 | −0.124 | 1.54E-02 | 0.329 | 5.15E-11 |
SNHG14 | hsa-miR-330-5p | −0.066 | 1.99E-01 | −0.029 | 5.72E-01 | 0.195 | 1.37E-04 |
OIP5-AS1 | hsa-miR-330-5p | −0.074 | 1.52E-01 | −0.066 | 2.02E-01 | 0.141 | 5.87E-03 |
AC020891.2 | hsa-miR-330-5p | −0.017 | 7.48E-01 | 0.084 | 1.02E-01 | 0.077 | 1.33E-01 |
AC090970.3 | hsa-miR-330-5p | 0.138 | 7.26E-03 | 0.063 | 2.24E-01 | −0.015 | 7.65E-01 |
AC010999.3 | hsa-miR-330-5p | 0 | 0.00E+00 | 0 | 0.00E+00 | 0 | 0.00E+00 |
AC018904.2 | hsa-miR-330-5p | 0.065 | 2.07E-01 | −0.144 | 4.94E-03 | 0.038 | 4.66E-01 |
NPTN-IT1 | hsa-miR-330-5p | −0.004 | 9.38E-01 | −0.222 | 1.24E-05 | 0.188 | 2.24E-04 |
AL031008.1 | hsa-miR-330-5p | 0.01 | 8.50E-01 | −0.152 | 2.96E-03 | −0.003 | 9.51E-01 |
SNHG9 | hsa-miR-330-5p | −0.02 | 7.03E-01 | −0.033 | 5.18E-01 | −0.175 | 6.03E-04 |
AC012676.5 | hsa-miR-330-5p | −0.008 | 8.71E-01 | −0.096 | 6.33E-02 | 0.216 | 2.20E-05 |
SLX1A-SULT1A3 | hsa-miR-330-5p | −0.06 | 2.48E-01 | −0.054 | 2.91E-01 | 0.108 | 3.49E-02 |
AC007496.3 | hsa-miR-330-5p | −0.043 | 4.11E-01 | −0.104 | 4.25E-02 | 0.217 | 2.04E-05 |
AC026461.1 | hsa-miR-330-5p | 0 | 0.00E+00 | 0 | 1.00E+00 | 0 | 1.00E+00 |
AC040162.3 | hsa-miR-330-5p | −0.011 | 8.29E-01 | −0.111 | 3.11E-02 | 0.07 | 1.71E-01 |
AC126773.2 | hsa-miR-330-5p | −0.036 | 4.90E-01 | 0.025 | 6.32E-01 | 0.358 | 6.49E-13 |
AC009022.1 | hsa-miR-330-5p | 0.066 | 1.99E-01 | −0.177 | 5.56E-04 | 0.121 | 1.82E-02 |
*These results are statistically significant.
In the ovarian cancer TCGA database, lncRNAs that are significantly related to hsa-mir-330-5p are shown in red.